EVQLV Company
Leveraging advances in computation to revolutionize the design and development of therapeutic antibodies
Investors
Founded Date:
2019-12-15
Total Funding:
360000.0
Investor Type:
N/A
Employee Number:
1-10
Investment Stage:
N/A
Funding Status:
Seed
Number Of Exists:
N/A
Technology:
Artificial Intelligence, Biotechnology, Health Care, Life Science, Machine Learning, Pharmaceutical
Last Funding Type:
Grant
Investors Number:
6.0
Last Funding Date:
2023-02-13
Industry:
Early Drug Development
Headquarters:
New York, New York, United States